Newark, New Castle, USA, April 20, 2023 (GLOBE NEWSWIRE) — According to the most recent study by Growth Plus Reports, the global Eosinophilia-Myalgia Syndrome Market is expected to register a revenue CAGR of 3.28% by 2031. The global market for eosinophilia-myalgia syndrome was analyzed, and it is expected to rise…Read More
Related Posts
CHOP and Penn Medicine researchers develop in vivo RNAbased gene
Philadelphia, July 28, 2023 -- In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the…
Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit…
Hospitals pioneering gene therapy aims to free patients of blood disease Is a cure at…
SAN JOSE, Calif. -- Faith in God called Clint and Alissa Finlayson to adopt two sick girls from an orphanage in China. Faith in medicine called them to Oakland.
